Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
• Innovent Biologics Inc. (1801:HK) (IVBXF) PT Raised to HK$128 at Bernstein SocGen Group